risk of thyroid cancer with semaglutide (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, emerging human data showing higher thyroid in early users. Over 2,900 lawsuits allege inadequate warnings for Popular diabetes drugs do not

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support

As maintaining a healthy weight lowers the risk of developing a multitude of diseases, you may benefit from the programme if you: Managing your weight is not just about numbers on a scale or fitting into a certain image

Some patients have also reported appetite suppression and reduced cravings effects that may benefit those struggling with portion control

(call/text 480.939.4669) Appointments can be conducted in person or virtual via phone call

Role of Healthcare Providers in Managing Blood Clot Risk Healthcare providers have the expertise to assess, manage, and mitigate the risk of blood clots in patients taking semaglutide